Unmet needs in lung cancer from a patient perspective

Amy Moore, PhD, Lungevity Foundation, USA, discusses the importance of widening access to new effective therapies across the world, and strategies to achieve this. This interview took place at the International Society of Liquid Biopsy (ISLB) 2022 congress in Miami, FL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.